Parameter Immunoassay Control Set 870 for cGMP

For use with catalog numbers KGE003, SKGE003, PKGE003

Discontinued Product

QC54 has been discontinued.
View all cGMP products.
R&D Systems ELISA Controls
1 Image
Product Details
Citations (3)
FAQs
Reviews

Parameter Immunoassay Control Set 870 for cGMP Summary

INTENDED USE & DESCRIPTION

For use as quantitative controls for the determination of cytokine concentrations in biological fluids. Concentrations have been assigned using R&D Systems’ Parameter® kits. Controls are prepared in diluted porcine serum with preservatives. They contain recombinant human cytokines at low, medium and high concentrations. Controls are supplied lyophilized.

STORAGE & STABILITY

Unreconstituted Controls should be stored at 2-8 °C and are stable for at least 6 months from date of receipt. Depending on the analyte of interest, reconstituted controls may be stable when stored at < -20 °C. Users should evaluate the frozen stability of the controls in their application or discard after use.

REAGENT PREPARATION

Reconstitute each vial with the volume of deionized or distilled water indicated on the product datasheet.

PROCEDURE & EXPECTED VALUES

Controls should be assayed in the same manner as unknown specimens.

The acceptable ranges for the analytes in these controls are printed on the product datasheet. Due to possible variations in techniques and methodologies, it is recommended that each laboratory determine its own target range. Laboratories using other test systems should establish their own acceptable ranges as these assays may produce different values.

TECHNICAL HINTS & LIMITATIONS OF THE PROCEDURE 

• The ranges were determined using R&D Systems’ Parameter kits. If expected values are not obtained, verify that the lot numbers on the vials correspond with the lot numbers listed above and the correct volume of deionized or distilled water was used for reconstitution of the controls. 

• The results obtained with these controls depend upon several factors associated with methods and instrumentation. Test systems other than those supplied by R&D Systems may result in values that differ from those printed on this product datasheet.

Specifications

Source
N/A
Shipping Conditions
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Storage
Store the unopened product at 2 - 8 °C. Do not use past expiration date.
Applications
Control
Species
Multi-Species

Product Datasheets

You must select a language.

x

Background: cGMP

Guanosine 3, 5-cyclic monophosphate (cGMP) is formed via the action of guanylate cyclase on GTP. cGMP is present at levels typically 10-100 fold lower than cAMP in most tissues. A variety of stimuli including acetylcholine, insulin, oxytocin, serotonin, and histamine will cause an increase in cGMP levels. Various stimulators of guanylate cyclase (e.g. vasodilators) as well as peptides that relax smooth muscle also increase cGMP concentrations.

Long Name
Cyclic GMP
Alternate Names
cGMP

Citations for Parameter Immunoassay Control Set 870 for cGMP

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

3 Citations: Showing 1 - 3
Filter your results:

Filter by:

  1. A randomised placebo controlled trial of VSL#3� probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver disease
    Authors: PL Chong, D Laight, RJ Aspinall, A Higginson, MH Cummings
    BMC gastroenterology, 2021-04-01;21(1):144.  2021-04-01
  2. Natriuretic Peptide Expression and Function in GH3 Somatolactotropes and Feline Somatotrope Pituitary Tumours
    Authors: SM Mirczuk, CJ Scudder, JE Read, VJ Crossley, JT Regan, KM Richardson, B Simbi, CA McArdle, DB Church, J Fenn, PJ Kenny, HA Volk, CP Wheeler-Jo, M Korbonits, SJ Niessen, IM McGonnell, RC Fowkes
    International Journal of Molecular Sciences, 2021-01-22;22(3):.  2021-01-22
  3. Cardiorenal and endocrine effects of synthetic canine BNP1-32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease
    Authors: M Yata, HS Kooistra, NJ Beijerink
    J. Vet. Intern. Med., 2019-01-31;0(0):.  2019-01-31

FAQs

No product specific FAQs exist for this product, however you may

View all ELISA FAQs

Reviews for Parameter Immunoassay Control Set 870 for cGMP

There are currently no reviews for this product. Be the first to review Parameter Immunoassay Control Set 870 for cGMP and earn rewards!

Have you used Parameter Immunoassay Control Set 870 for cGMP?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review